These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 9799653

  • 21. Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the beta1-adrenergic receptor.
    Engelhardt S, Boknik P, Keller U, Neumann J, Lohse MJ, Hein L.
    FASEB J; 2001 Dec; 15(14):2718-20. PubMed ID: 11606476
    [Abstract] [Full Text] [Related]

  • 22. Nuclear targeting of Akt enhances ventricular function and myocyte contractility.
    Rota M, Boni A, Urbanek K, Padin-Iruegas ME, Kajstura TJ, Fiore G, Kubo H, Sonnenblick EH, Musso E, Houser SR, Leri A, Sussman MA, Anversa P.
    Circ Res; 2005 Dec 09; 97(12):1332-41. PubMed ID: 16293788
    [Abstract] [Full Text] [Related]

  • 23. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions.
    Mattiazzi A, Mundiña-Weilenmann C, Guoxiang C, Vittone L, Kranias E.
    Cardiovasc Res; 2005 Dec 01; 68(3):366-75. PubMed ID: 16226237
    [Abstract] [Full Text] [Related]

  • 24. Phospholamban: a protein coming of age.
    Kadambi VJ, Kranias EG.
    Biochem Biophys Res Commun; 1997 Oct 09; 239(1):1-5. PubMed ID: 9345259
    [Abstract] [Full Text] [Related]

  • 25. Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle.
    Linck B, Bokník P, Baba HA, Eschenhagen T, Haverkamp U, Jäckel E, Jones LR, Kirchhefer U, Knapp J, Läer S, Müller FU, Schmitz W, Scholz H, Syska A, Vahlensieck U, Neumann J.
    J Pharmacol Exp Ther; 1998 Jul 09; 286(1):531-8. PubMed ID: 9655899
    [Abstract] [Full Text] [Related]

  • 26. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P, Kranias EG.
    Arch Mal Coeur Vaiss; 2005 Dec 09; 98(12):1239-43. PubMed ID: 16435604
    [Abstract] [Full Text] [Related]

  • 27. Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2.
    Kirchhefer U, Baba HA, Bokník P, Breeden KM, Mavila N, Brüchert N, Justus I, Matus M, Schmitz W, Depaoli-Roach AA, Neumann J.
    Cardiovasc Res; 2005 Oct 01; 68(1):98-108. PubMed ID: 15975567
    [Abstract] [Full Text] [Related]

  • 28. PKC-alpha regulates cardiac contractility and propensity toward heart failure.
    Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, Molkentin JD.
    Nat Med; 2004 Mar 01; 10(3):248-54. PubMed ID: 14966518
    [Abstract] [Full Text] [Related]

  • 29. Phospholamban and cardiac contractile function.
    Brittsan AG, Kranias EG.
    J Mol Cell Cardiol; 2000 Dec 01; 32(12):2131-9. PubMed ID: 11112989
    [No Abstract] [Full Text] [Related]

  • 30. The effects of a thyroid hormone analog on left ventricular performance and contractile and calcium cycling proteins in the baboon.
    Hoit BD, Pawloski-Dahm CM, Shao Y, Gabel M, Walsh RA.
    Proc Assoc Am Physicians; 1997 Mar 01; 109(2):136-45. PubMed ID: 9069582
    [Abstract] [Full Text] [Related]

  • 31. Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation.
    Tang T, Lai NC, Roth DM, Drumm J, Guo T, Lee KW, Han PL, Dalton N, Gao MH.
    Basic Res Cardiol; 2006 Mar 01; 101(2):117-26. PubMed ID: 16283593
    [Abstract] [Full Text] [Related]

  • 32. Differential phospholamban gene expression in murine cardiac compartments. Molecular and physiological analyses.
    Koss KL, Ponniah S, Jones WK, Grupp IL, Kranias EG.
    Circ Res; 1995 Aug 01; 77(2):342-53. PubMed ID: 7542181
    [Abstract] [Full Text] [Related]

  • 33. Overexpression of phospholamban in slow-twitch skeletal muscle is associated with depressed contractile function and muscle remodeling.
    Song Q, Young KB, Chu G, Gulick J, Gerst M, Grupp IL, Robbins J, Kranias EG.
    FASEB J; 2004 Jun 01; 18(9):974-6. PubMed ID: 15059971
    [Abstract] [Full Text] [Related]

  • 34. Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts.
    Baker DL, Hashimoto K, Grupp IL, Ji Y, Reed T, Loukianov E, Grupp G, Bhagwhat A, Hoit B, Walsh R, Marban E, Periasamy M.
    Circ Res; 2004 Jun 01; 83(12):1205-14. PubMed ID: 9851937
    [Abstract] [Full Text] [Related]

  • 35. Monomeric phospholamban overexpression in transgenic mouse hearts.
    Chu G, Dorn GW, Luo W, Harrer JM, Kadambi VJ, Walsh RA, Kranias EG.
    Circ Res; 1997 Oct 01; 81(4):485-92. PubMed ID: 9314829
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Altered phospholamban-calcium ATPase interaction in cardiac sarcoplasmic reticulum during the progression of sepsis.
    Wu LL, Tang C, Dong LW, Liu MS.
    Shock; 2002 May 01; 17(5):389-93. PubMed ID: 12022759
    [Abstract] [Full Text] [Related]

  • 40. Preservation of the in vivo phosphorylation status of phospholamban in the heart: evidence for a site-specific difference in the dephosphorylation of phospholamban.
    Calaghan S, White E, Colyer J.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):701-5. PubMed ID: 9703990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.